Zobrazeno 1 - 10
of 1 348
pro vyhledávání: '"Bennink, J. R."'
Autor:
Mosmann TR; David H. Smith Center for Vaccine Biology and Immunology, University of Rochester Medical Center, Rochester, NY, USA. tim_mosmann@urmc.rochester.edu., McMichael AJ; Centre for Immuno-Oncology, Old Road Campus Research Building, University of Oxford, Oxford, UK., LeVert A; Osivax, Lyon, France., McCauley JW; The Francis Crick Institute, London, UK., Almond JW; The Sir William Dunn School of Pathology, South Parks Road, University of Oxford, Oxford, UK.
Publikováno v:
Nature reviews. Immunology [Nat Rev Immunol] 2024 Oct; Vol. 24 (10), pp. 736-752. Date of Electronic Publication: 2024 May 02.
Publikováno v:
Scopus-Elsevier
MHC class I molecules predominantly bind to peptides derived from a cytosolic pool of polypeptides. Little is known about the nature of the polypeptides that serve as substrates for peptidogenic cytosolic proteases. We propose that a significant sour
Publikováno v:
Scopus-Elsevier
Under most circumstances, cell surface MHC class I molecules display peptides derived from a cytosolic pool of proteins. The efficient presentation of such peptides requires the functioning of two MHC gene products [TAP1 and TAP2 (transporter-associa
Autor:
Torrance, Blake L.1,2 (AUTHOR), Cadar, Andreia N.1,2 (AUTHOR), Panier, Hunter A.3 (AUTHOR), Martin, Dominique E.1,2 (AUTHOR), Lorenzo, Erica C.1 (AUTHOR), Jellison, Evan R.2 (AUTHOR), Bartley, Jenna M.1,2 (AUTHOR), Haynes, Laura1,2 (AUTHOR) lhaynes@uchc.edu
Publikováno v:
Aging Cell. Jul2024, Vol. 23 Issue 7, p1-12. 12p.
Autor:
O Neil, B. H., Kawakami, Y., Nicholas P. Restifo, Bennink, J. R., Yewdell, J. W., Rosenberg, S. A.
Publikováno v:
Scopus-Elsevier
To detect shared human melanoma Ag that are recognized by HLA-A2 restricted, melanoma-specific CTL derived from tumor infiltrating lymphocytes, we have developed a convenient method to insert and express foreign HLA genes capable of presenting Ag on
Autor:
Nicholas P. Restifo, Esquivel, F., Asher, A. L., Stötter, H., Barth, R. J., Bennink, J. R., Mulé, J. J., Yewdell, J. W., Rosenberg, S. A.
Publikováno v:
Scopus-Elsevier
MHC class I-restricted CTL play a central role in the immune response against methylcholanthrene (MCA)-induced sarcomas in mice. We, therefore, hypothesized that MCA-induced tumors may evade immune recognition by failing to present Ag to CD8+ CTL. Of
Autor:
Deng, Y., Gibbs, J., Bačík, I., Porgador, A., Copeman, J., Paul Joseph Lehner, Ortmann, B., Cresswell, P., Bennink, J. R., Yewdell, J. W.
Publikováno v:
Scopus-Elsevier
To study the requirements for assembly of MHC class I molecules with antigenic peptides in the endoplasmic reticulum (ER), we studied Ag processing in insect cells. Insects lack a class I recognition system, and their cells therefore provide a “bla
Autor:
de Cavanagh, Elena M. V.1 (AUTHOR) elenacavanagh@yahoo.com.ar, Inserra, Felipe2,3 (AUTHOR), Ferder, León2 (AUTHOR)
Publikováno v:
Physiological Reports. Jun2024, Vol. 12 Issue 12, p1-31. 31p.
Autor:
Doherty, P. C., Bennink, J. R.
Publikováno v:
Scandinavian Journal of Immunology; Oct1980, Vol. 12 Issue 4, p271-280, 10p
Autor:
da Silva Antunes R; Center for Vaccine Innovation, La Jolla Institute for Immunology (LJI), La Jolla, California., Weiskopf D; Center for Vaccine Innovation, La Jolla Institute for Immunology (LJI), La Jolla, California., Sidney J; Center for Vaccine Innovation, La Jolla Institute for Immunology (LJI), La Jolla, California., Rubiro P; Center for Vaccine Innovation, La Jolla Institute for Immunology (LJI), La Jolla, California., Peters B; Center for Vaccine Innovation, La Jolla Institute for Immunology (LJI), La Jolla, California.; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, California., Lindestam Arlehamn CS; Center for Vaccine Innovation, La Jolla Institute for Immunology (LJI), La Jolla, California., Grifoni A; Center for Vaccine Innovation, La Jolla Institute for Immunology (LJI), La Jolla, California., Sette A; Center for Vaccine Innovation, La Jolla Institute for Immunology (LJI), La Jolla, California.; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, California.
Publikováno v:
Current protocols [Curr Protoc] 2023 Nov; Vol. 3 (11), pp. e934.